Showing 2,181 - 2,200 results of 2,687 for search '"chemotherapy"', query time: 0.07s Refine Results
  1. 2181

    Burkitt’s Lymphoma Presented as Advanced Ovarian Cancer without Evidence of Lymphadenopathy: CT and MRI Findings by Lucia Manganaro, Silvia Bernardo, Maria Eleonora Sergi, Paolo Sollazzo, Valeria Vinci, Alessandra De Grazia, Anna Clerico, Maria Giovanna Mollace, Matteo Saldari

    Published 2013-01-01
    “…We describe the MRI and CT findings of simultaneous ovarian and bone lesions, which have never been reported in literature in a patient with Burkitt's lymphoma, before and after one cycle of chemotherapy. In evaluating any ovarian neoplasm in a young woman, Burkitt's lymphoma should be considered as a possibility, particularly if associated with bone lesions. …”
    Get full text
    Article
  2. 2182

    Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature by Hiroshi Katoh, Tomoya Mitsuma, Riku Okamoto, Kanako Naito, Takaaki Tokito, Mariko Kikuchi, Takafumi Sangai

    Published 2024-11-01
    “…Parathyroid cancer (PC) is extremely resistant to chemotherapy and radiotherapy (RT), but hormonally functional by producing excessive parathyroid hormone (PTH), causing remarkable hypercalcemia even in biochemical disease recurrence. …”
    Get full text
    Article
  3. 2183

    Papillary Carcinoma of Breast: Clinicopathological Characteristics, Management, and Survival by Bushra Rehman, Anam Mumtaz, Barka Sajjad, Namra Urooj, Sameen Mohtasham Khan, M. Toqeer Zahid, Huma Mannan, M. Zulqarnain Chaudhary, Amina Khan, M. Asad Parvaiz

    Published 2022-01-01
    “…Breast conservation surgery (BCS) was performed in 34 (58.6%) and mastectomy in 22 (37.9%) patients. 13 patients did not undergo invasive axillary staging; the rest of 43 (74%) patients did (32 sentinel biopsy and 11 axillary dissection). Chemotherapy was given to 18 patients (31%), mostly to IPC (n=12). …”
    Get full text
    Article
  4. 2184

    Cost-effectiveness of comparative survey designs for helminth control programs: Post-hoc cost analysis and modelling of the Kenyan national school-based deworming program. by Mark Minnery, Collins Okoyo, Grace Morgan, Andrew Wang, Olatunji Johnson, Claudio Fronterre, Antonio Montresor, Suzy J Campbell, Charles Mwandawiro, Peter Diggle

    Published 2024-12-01
    “…<h4>Background</h4>Soil-transmitted helminths (STH) and schistosomiasis comprise the most wide-spread NTDs globally. Preventative chemotherapy is a cost-effective approach to controlling morbidity of both diseases, but relies on large scale surveys to determine and revise treatment frequency. …”
    Get full text
    Article
  5. 2185

    Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer by Brock J. Sishc, Janapriya Saha, Elizabeth M. Alves, Lianghao Ding, Huiming Lu, Shih-Ya Wang, Katy L. Swancutt, James H. Nicholson, Angelica Facoetti, Arnold Pompos, Mario Ciocca, Todd A. Aguilera, Michael D. Story, Anthony J. Davis

    Published 2025-01-01
    “…Abstract Pancreatic ductal adenocarcinoma (PDAC) is notably resistant to conventional chemotherapy and radiation treatment. However, clinical trials indicate that carbon ion radiotherapy (CIRT) with concurrent gemcitabine is effective for unresectable locally advanced PDAC. …”
    Get full text
    Article
  6. 2186

    The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells by Sabrina Bimonte, Maddalena Leongito, Antonio Barbieri, Vitale del Vecchio, Michela Falco, Aldo Giudice, Raffaele Palaia, Vittorio Albino, Raimondo Di Giacomo, Antonella Petrillo, Vincenza Granata, Francesco Izzo

    Published 2016-01-01
    “…MicroRNAs (miRNAs) are able to regulate a lot of biological processes such as self-renewal and pluripotency of HCSCs, representing a new promising strategy for treatment of HCC chemotherapy-resistant tumors. In this review, we synthesize the latest findings on therapeutic regulation of HCSCs by miRNAs, in order to highlight the perspective of novel miRNA-based anticancer therapies for HCC treatment.…”
    Get full text
    Article
  7. 2187

    CD4+CD25highCD127low/−FoxP3+ Regulatory T Cell Subpopulations in the Bone Marrow and Peripheral Blood of Children with ALL: Brief Report by M. Niedźwiecki, O. Budziło, M. Zieliński, E. Adamkiewicz-Drożyńska, L. Maciejka-Kembłowska, T. Szczepański, P. Trzonkowski

    Published 2018-01-01
    “…Furthermore, statistical analysis revealed low negative correlation between the number of Tregs in the bone marrow and the minimal residual disease measured on day 15th, the percentage of blasts in the bone marrow and leukocytosis after 15 days of chemotherapy. These results indicate the influence of Tregs on the final therapeutic effect.…”
    Get full text
    Article
  8. 2188

    A Woman with a Long History of Smoking and a Debilitating Dry Cough by N. D. Potskhverashvili, N. I. Kokina, E. L. Bueverova, O. Yu. Zolnikova, A. S. Cherenda, V. A. Morozova, M. V. Feldsherov, A. P. Kiryukhin, P. V. Pavlov

    Published 2024-08-01
    “…Surgical treatment was performed at the Sechenov University surgical hospital: right-sided hemicolectomy with D2 lymph dissection (removal of epicolic, paracolic, mesocolic lymph nodes); adjuvant chemotherapy was prescribed. The patient is under the supervision of an oncologist and a coloproctologist.Conclusion. …”
    Get full text
    Article
  9. 2189

    A dynamic co-expression approach reveals Gins2 as a potential upstream modulator of HNSCC metastasis by Nasibeh Khayer, Samira Shabani, Maryam Jalessi, Mohammad Taghi Joghataei, Frouzandeh Mahjoubi

    Published 2025-01-01
    “…Current therapeutic options remain limited to surgery supplemented by radio- or chemotherapy; however, these interventions often result in high-grade toxicities. …”
    Get full text
    Article
  10. 2190

    Case report: A rare case of delayed drug-induced hyponatremia in recurrent upper tract urothelial carcinoma following GC and Tislelizumab treatment by Zhi-Jie Wang, Zhi-Jie Wang, Ying-Fang Nie, Shi-Bing Liang, Shi-Bing Liang, Shi-Bing Liang, Jing Zhou, Shu-Lan Hao, Li-Kun Liu

    Published 2025-01-01
    “…Tislelizumab alone for maintenance may be an option for those intolerant of chemotherapy. But Na+ decrease may be related to Tirelizumab or Gemcitabine, needing more clinical observation and experiments.…”
    Get full text
    Article
  11. 2191

    Ascitic Fluid in Ovarian Mass with Special Reference to Paired-box Gene 8 Immunoexpression: A Cross-sectional Analysis by Prabhat Mahato, Chhanda Das, Rama Saha, Ankita Pranab Mandal, Gourisankar Kamilya

    Published 2024-12-01
    “…Patients with ovarian mass and ascites can be evaluated for PAX8 status in their ascitic fluid cytology study for the purpose of neoadjuvant chemotherapy.…”
    Get full text
    Article
  12. 2192

    Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma by Lin Wang, Xinyu Liu, Haoze Lv, Han Zhang, Rimei Lin, Shan Xu, Chaojing Zhang, Shilei Lou, Zhidong Qiu, Cong Sun, Ning Cui

    Published 2025-01-01
    “…Recent studies on how natural products regulate miRNAs to reduce tumor cell resistance to chemotherapy are also reviewed. Furthermore, the review elaborates on how natural products regulate m6A modifications to influence miRNA expression, thereby exerting antitumor effects. …”
    Get full text
    Article
  13. 2193

    Mass resection as a candidate treatment for uterine PEComas of uncertain malignant potential: a case report and literature review by Haijuan Shi, Yan Yin, Shoujun Liang, Chuanzhong Liu, Yibao Huang, Bingfeng Lu, Liying Zhang

    Published 2025-01-01
    “…Most of the patients (11/13) were managed surgically without any chemotherapy or radiation therapy. Except for the patients who were lost to follow-up, 11 patients were free of any recurrence or metastasis at their last follow-up. …”
    Get full text
    Article
  14. 2194

    Tailoring cell-inspired biomaterials to fuel cancer therapy by Qi-Hui Wang, Shi Cheng, Chun-Yu Han, Shuang Yang, Sheng-Rui Gao, Wan-Zhong Yin, Wen-Zhi Song

    Published 2025-02-01
    “…Traditional cancer treatments, including surgery, radiotherapy, and chemotherapy, are effective yet face challenges like normal tissue damage, complications, and drug resistance. …”
    Get full text
    Article
  15. 2195

    Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients by Mario Delia, Paola Carluccio, Anna Mestice, Claudia Brunetti, Francesco Albano, Giorgina Specchia

    Published 2018-01-01
    “…We studied 23 AML young patients, all treated with standard induction chemotherapy: OR (complete remission (CR) + CR incomplete (CRi)) was documented in 10 of 23 patients (44%); there were two partial responder patients. …”
    Get full text
    Article
  16. 2196

    Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study by Yao Zhang, Shicong Zeng, Zongwen Wang, Qiankun Zhu, Jingtao Li, Xiaohang Ren, Shuoheng Ma, Gang Tan, Bo Zhai

    Published 2025-01-01
    “…Additionally, independent risk factors for CVM included age, marital status, calendar year of diagnosis, disease differentiation degree, SEER stage, and chemotherapy status. Conclusions SBA patients exhibited a substantially elevated risk of developing CVM compared to the general US population. …”
    Get full text
    Article
  17. 2197

    Tactics of the treatment of left atrial angiosarcoma by R.M. Vitovskyi, V.V. Isaіenko, D.М. Dyadyun, O.A. Pishchurin, V.F. Onishchenko, Ya.R. Ivanov, O.V. Kupchinskyi

    Published 2019-10-01
    “…The control CT studies after a course of chemotherapy recorded moderate tumor growth in the projection of the lung tissue; there was no recurrent tumor growth in the cavity of the LA. …”
    Get full text
    Article
  18. 2198

    High output stoma after surgery for rectal cancer - a risk factor for low anterior resection syndrome? by Xuena Zhang, Qingyu Meng, Jianna Du, Zhongtao Tian, Yinju Li, Bin Yu, Wenbo Niu

    Published 2025-01-01
    “…Subgroup analysis revealed that this association was more pronounced in older patients (age > 60), those without hypertension, with N0-N1 staging, a history of chemotherapy, and longer stoma closure intervals (Q3, Q4). …”
    Get full text
    Article
  19. 2199

    Laparoscopic and Endoscopic cooperative surgery as Rescue-treatment for Advanced gastric Cancer in patients Unfit for Surgery (LE-RACUS): protocol for a feasibility study by Henrik Maltzman, Masami Omae, Fredrik Klevebro, Francisco Baldaque-Silva, Ioannis Rouvelas

    Published 2025-01-01
    “…Abstract Background The standard treatment for advanced gastric cancer without metastasis is gastrectomy in combination with chemotherapy. Some patients cannot tolerate such treatment because of old age or comorbidities. …”
    Get full text
    Article
  20. 2200

    Down syndrome with cryptorchidism and retroperitoneal mixed germ cell tumour in an adult patient: a case report and literature review by Qiang Wang, Hai-bin Zhou, Li Ao, Yi Jiang, Xiao-Cong Zhou

    Published 2025-01-01
    “…Consequently, the patient underwent chemotherapy, and after one course of treatment, the patient developed bone marrow suppression. …”
    Get full text
    Article